Clinical trials
Phase 3 Respiratory Syncytial Virus Infections trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2015 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 6 |
| 2022 | 5 |
| 2023 | 3 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 16 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 15 |
| Pfizer | 2 |
| AstraZeneca | 1 |
| Bavarian Nordic | 1 |
| MedImmune LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 1 |
| Novavax | 1 |
| Regeneron Pharmaceuticals | 1 |
| University of Alabama at Birmingham | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Respiratory Syncytial Virus Infections | 25 |
| Infections | 1 |
| Tetanus | 1 |
Trials
Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.